(LLYVA) Liberty Live Holdings - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5312297485
Stock: Live Events, Ticket Sales, Advertising, Sponsorship
Total Rating 28
Risk 79
Buy Signal -0.21
| Risk 5d forecast | |
|---|---|
| Volatility | 33.7% |
| Relative Tail Risk | -10.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.27 |
| Alpha | -7.57 |
| Character TTM | |
|---|---|
| Beta | 0.975 |
| Beta Downside | 0.969 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.36% |
| CAGR/Max DD | 1.56 |
Description: LLYVA Liberty Live Holdings January 06, 2026
Liberty Live Holdings, Inc. (NASDAQ: LLYVA) is a U.S.-based live-entertainment operator that promotes concerts, sells tickets directly and for third-party venues, provides advertising and sponsorship services, and maintains a diversified portfolio of public and private equity investments.
Key industry metrics that shape Liberty Live’s outlook include the post-pandemic rebound in discretionary spending-U.S. consumer confidence has risen 12 % YoY, boosting ticket-sale volumes-and the accelerating shift to digital ticketing, which now accounts for roughly 68 % of all ticket transactions. The company’s comparable EBITDA margin historically hovers around 18 %, while average ticket prices in its primary markets have trended upward at ~4 % annually, reflecting both inflationary pressures and premium-experience demand.
For a deeper, data-driven assessment of LLYVA’s valuation and risk profile, you may want to explore the analytics available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -269.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 6.57 > 1.0 |
| NWC/Revenue: error (cannot be calculated; needs Current Assets/Liabilities and Revenue current+prev) |
| CFO/TA 0.05 > 3% & CFO 828.4m > Net Income -269.0m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.47 > 1.5 & < 3 |
| Outstanding Shares: last quarter (91.8m) vs 12m ago 0.12% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 283.5% > 50% (prev 0.0%; Δ 283.5% > 0%) |
| Interest Coverage Ratio: -1.19 > 6 (EBITDA TTM -52.0m / Interest Expense TTM 108.0m) |
Altman Z'' 1.40
| A: -0.11 (Total Current Assets 1.65b - Total Current Liabilities 3.53b) / Total Assets 17.11b |
| B: 0.43 (Retained Earnings 7.44b / Total Assets 17.11b) |
| C: -0.01 (EBIT TTM -129.0m / Avg Total Assets 9.18b) |
| D: 0.76 (Book Value of Equity 7.38b / Total Liabilities 9.73b) |
| Altman-Z'' Score: 1.40 = BB |
What is the price of LLYVA shares?
As of February 07, 2026, the stock is trading at USD 80.01 with a total of 95,444 shares traded.
Over the past week, the price has changed by -0.53%, over one month by -2.20%, over three months by -1.53% and over the past year by +7.93%.
Over the past week, the price has changed by -0.53%, over one month by -2.20%, over three months by -1.53% and over the past year by +7.93%.
Is LLYVA a buy, sell or hold?
Liberty Live Holdings has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy LLYVA.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LLYVA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 106 | 32.5% |
| Analysts Target Price | 106 | 32.5% |
| ValueRay Target Price | 92.4 | 15.5% |
LLYVA Fundamental Data Overview February 04, 2026
P/E Forward = 40.6504
P/S = 675.9385
P/B = 0.3351
Revenue TTM = 26.03b USD
EBIT TTM = -129.0m USD
EBITDA TTM = -52.0m USD
Long Term Debt = 1.56b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.92b USD (from shortTermDebt, last quarter)
Debt = 1.92b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 327.0m USD (from netDebt column, last quarter)
Enterprise Value = 7.91b USD (7.58b + Debt 1.92b - CCE 1.59b)
Interest Coverage Ratio = -1.19 (Ebit TTM -129.0m / Interest Expense TTM 108.0m)
EV/FCF = 9.44x (Enterprise Value 7.91b / FCF TTM 837.8m)
FCF Yield = 10.59% (FCF TTM 837.8m / Enterprise Value 7.91b)
FCF Margin = 3.22% (FCF TTM 837.8m / Revenue TTM 26.03b)
Net Margin = -1.03% (Net Income TTM -269.0m / Revenue TTM 26.03b)
Gross Margin = 93.48% ((Revenue TTM 26.03b - Cost of Revenue TTM 1.70b) / Revenue TTM)
Gross Margin QoQ = 41.84% (prev 41.91%)
Tobins Q-Ratio = 0.46 (Enterprise Value 7.91b / Total Assets 17.11b)
Interest Expense / Debt = 4.49% (Interest Expense 86.0m / Debt 1.92b)
Taxrate = 21.0% (US default 21%)
NOPAT = -101.9m (EBIT -129.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.47 (Total Current Assets 1.65b / Total Current Liabilities 3.53b)
Debt / Equity = 0.26 (Debt 1.92b / totalStockholderEquity, last quarter 7.38b)
Debt / EBITDA = -6.29 (negative EBITDA) (Net Debt 327.0m / EBITDA -52.0m)
Debt / FCF = 0.39 (Net Debt 327.0m / FCF TTM 837.8m)
Total Stockholder Equity = 1.53b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.93% (Net Income -269.0m / Total Assets 17.11b)
RoE = -17.55% (Net Income TTM -269.0m / Total Stockholder Equity 1.53b)
RoCE = -4.18% (EBIT -129.0m / Capital Employed (Equity 1.53b + L.T.Debt 1.56b))
RoIC = -8.35% (negative operating profit) (NOPAT -101.9m / Invested Capital 1.22b)
WACC = 8.31% (E(7.58b)/V(9.50b) * Re(9.51%) + D(1.92b)/V(9.50b) * Rd(4.49%) * (1-Tc(0.21)))
Discount Rate = 9.51% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.05%
[DCF Debug] Terminal Value 68.83% ; FCFF base≈837.8m ; Y1≈549.9m ; Y5≈250.9m
Fair Price DCF = 169.2 (EV 4.65b - Net Debt 327.0m = Equity 4.33b / Shares 25.6m; r=8.31% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -65.35 | EPS CAGR: -30.32% | SUE: -1.96 | # QB: 0
Revenue Correlation: 80.10 | Revenue CAGR: 21.18% | SUE: 0.09 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.01 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=1.99 | Chg30d=+0.350 | Revisions Net=+0 | Growth EPS=+130.5% | Growth Revenue=+513.0%
P/S = 675.9385
P/B = 0.3351
Revenue TTM = 26.03b USD
EBIT TTM = -129.0m USD
EBITDA TTM = -52.0m USD
Long Term Debt = 1.56b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.92b USD (from shortTermDebt, last quarter)
Debt = 1.92b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 327.0m USD (from netDebt column, last quarter)
Enterprise Value = 7.91b USD (7.58b + Debt 1.92b - CCE 1.59b)
Interest Coverage Ratio = -1.19 (Ebit TTM -129.0m / Interest Expense TTM 108.0m)
EV/FCF = 9.44x (Enterprise Value 7.91b / FCF TTM 837.8m)
FCF Yield = 10.59% (FCF TTM 837.8m / Enterprise Value 7.91b)
FCF Margin = 3.22% (FCF TTM 837.8m / Revenue TTM 26.03b)
Net Margin = -1.03% (Net Income TTM -269.0m / Revenue TTM 26.03b)
Gross Margin = 93.48% ((Revenue TTM 26.03b - Cost of Revenue TTM 1.70b) / Revenue TTM)
Gross Margin QoQ = 41.84% (prev 41.91%)
Tobins Q-Ratio = 0.46 (Enterprise Value 7.91b / Total Assets 17.11b)
Interest Expense / Debt = 4.49% (Interest Expense 86.0m / Debt 1.92b)
Taxrate = 21.0% (US default 21%)
NOPAT = -101.9m (EBIT -129.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.47 (Total Current Assets 1.65b / Total Current Liabilities 3.53b)
Debt / Equity = 0.26 (Debt 1.92b / totalStockholderEquity, last quarter 7.38b)
Debt / EBITDA = -6.29 (negative EBITDA) (Net Debt 327.0m / EBITDA -52.0m)
Debt / FCF = 0.39 (Net Debt 327.0m / FCF TTM 837.8m)
Total Stockholder Equity = 1.53b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.93% (Net Income -269.0m / Total Assets 17.11b)
RoE = -17.55% (Net Income TTM -269.0m / Total Stockholder Equity 1.53b)
RoCE = -4.18% (EBIT -129.0m / Capital Employed (Equity 1.53b + L.T.Debt 1.56b))
RoIC = -8.35% (negative operating profit) (NOPAT -101.9m / Invested Capital 1.22b)
WACC = 8.31% (E(7.58b)/V(9.50b) * Re(9.51%) + D(1.92b)/V(9.50b) * Rd(4.49%) * (1-Tc(0.21)))
Discount Rate = 9.51% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.05%
[DCF Debug] Terminal Value 68.83% ; FCFF base≈837.8m ; Y1≈549.9m ; Y5≈250.9m
Fair Price DCF = 169.2 (EV 4.65b - Net Debt 327.0m = Equity 4.33b / Shares 25.6m; r=8.31% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -65.35 | EPS CAGR: -30.32% | SUE: -1.96 | # QB: 0
Revenue Correlation: 80.10 | Revenue CAGR: 21.18% | SUE: 0.09 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.01 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=1.99 | Chg30d=+0.350 | Revisions Net=+0 | Growth EPS=+130.5% | Growth Revenue=+513.0%